Boehringer Ingelheim pledges EUR 11 billion to R&D
11 November 2015 | By Victoria White
Of the total investment, EUR 5 billion will go to preclinical R&D with EUR 1.5 billion thereof planned for collaborations with external partners...
List view / Grid view
Genomics is the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.
11 November 2015 | By Victoria White
Of the total investment, EUR 5 billion will go to preclinical R&D with EUR 1.5 billion thereof planned for collaborations with external partners...
30 October 2015 | By Victoria White
MD Anderson's Moon Shots Programme is an unprecedented effort and novel organisational model designed to more rapidly convert scientific discoveries into life-saving advances...
21 October 2015 | By Victoria White
The research team have changed how the genome is folded inside the nucleus. The advance may lead to new methods of understanding and overcoming genetic diseases...
19 October 2015 | By Victoria White
Genomics has entered into a collaboration agreement in a research project focused on the translation of whole genome sequencing into clinical practice...
8 October 2015 | By Avacta Life Sciences
In this webinar we discuss Affimer® technology, a novel antibody mimetic and powerful antibody alternative...
7 October 2015 | By Victoria White
Horizon Discovery Group has in-licensed novel kinase inhibitors from Servier that exhibit great promise based on preclinical data for treatment of a range of cancer types...
5 October 2015 | By Victoria White
Biogen will leverage findings from Genomics’ integrated database and analysis tools, which will be used to guide drug research and development...
2 October 2015 | By Victoria White
Understanding how genomic variants contribute to disease may help clinicians develop improved diagnostics and treatments, in addition to new methods of prevention...
29 September 2015 | By Victoria White
Congenica’s platform Sapientia has been developed to analyse and interpret whole genome data. With this grant Congenica will be able to extend its capability to include other types of -omics data...
23 September 2015 | By Victoria White
Inquiro gathers all unstructured data – from R&D to preclinical data – and allows researchers to organise and interconnect such data, facilitating large-scale collaborations among geographically distant research teams...
15 September 2015 | By IntelliCyt
Identification of antibodies against challenging targets using high throughput multiplex-screening approaches...
15 September 2015 | By Victoria White
DESKGEN allows researchers to expertly design and perform CRISPR-based genome editing experiments in virtually any cell line or species...
4 September 2015 | By Oxford Global
In the run up to our 2015 Next Generation Sequencing Congress, Single Cell Congress & Genome Editing Congress we spoke with Jacqueline Boultwood, University of Oxford, a confirmed speaker at the congress, about her thoughts on the current status of the sequencing industry...
2 September 2015 | By Victoria White
Nearly all advanced oesophageal cancers harbour genetic mutations that can be targeted with emerging drug therapies, according to a new study...
19 August 2015 | By Victoria White
Roche has signed a definitive agreement to acquire Kapa Biosystems, strengthening Roche's next-generation sequencing product offerings...